The US FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, amidst emerging coronavirus variants. It is approved for ...

The US FDA has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for use in adults aged 65 and older.

Moderna's updated COVID-19 vaccine has received FDA approval for individuals aged 65 and older, marking the first endorsement ...

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

The Trump administration's decision to halt a $258 million HIV vaccine research program has sparked widespread concern. This ...

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

RFK Jr. announced this week that the federal government is removing the recommendation that kids and pregnant women get ...

The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...

The Department of Health and Human Services (HHS) has canceled funding pledged to Moderna for the development of mRNA-based ...

The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, according ...

The White House said it will fix errors in a much-anticipated federal government report spearheaded by U.S. Health and Human ...